Literature DB >> 19743411

Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins.

Guang Yang1, Qingrun Li, Siyuan Ren, Xuefeng Lu, Longhou Fang, Wenchao Zhou, Fan Zhang, Feilai Xu, Zhe Zhang, Rong Zeng, Friedrich Lottspeich, Zhengjun Chen.   

Abstract

C-terminal Src kinase (Csk) that functions as an essential negative regulator of Src family tyrosine kinases (SFKs) interacts with tyrosine-phosphorylated molecules through its Src homology 2 (SH2) domain, allowing it targeting to the sites of SFKs and concomitantly enhancing its kinase activity. Identification of additional Csk-interacting proteins is expected to reveal potential signaling targets and previously undescribed functions of Csk. In this study, using a direct proteomic approach, we identified 151 novel potential Csk-binding partners, which are associated with a wide range of biological functions. Bioinformatics analysis showed that the majority of identified proteins contain one or several Csk-SH2 domain-binding motifs, indicating a potentially direct interaction with Csk. The interactions of Csk with four proteins (partitioning defective 3 (Par3), DDR1, SYK and protein kinase C iota) were confirmed using biochemical approaches and phosphotyrosine 1127 of Par3 C-terminus was proved to directly bind to Csk-SH2 domain, which was consistent with predictions from in silico analysis. Finally, immunofluorescence experiments revealed co-localization of Csk with Par3 in tight junction (TJ) in a tyrosine phosphorylation-dependent manner and overexpression of Csk, but not its SH2-domain mutant lacking binding to phosphotyrosine, promoted the TJ assembly in Madin-Darby canine kidney cells, implying the involvement of Csk-SH2 domain in regulating cellular TJs. In conclusion, the newly identified potential interacting partners of Csk provided new insights into its functional diversity in regulation of numerous cellular events, in addition to controlling the SFK activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19743411     DOI: 10.1002/pmic.200800762

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Numb: A new player in EMT.

Authors:  Zezhou Wang; Shawn S-C Li
Journal:  Cell Adh Migr       Date:  2010-04-16       Impact factor: 3.405

Review 2.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Modified SH2 domain to phototrap and identify phosphotyrosine proteins from subcellular sites within cells.

Authors:  Akiyoshi Uezu; Hirokazu Okada; Hideji Murakoshi; Cosmo D del Vescovo; Ryohei Yasuda; Dario Diviani; Scott H Soderling
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

Review 4.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

Review 5.  Discoidin domain receptors: a proteomic portrait.

Authors:  Leo K Iwai; Maciej T Luczynski; Paul H Huang
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

6.  Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Authors:  Huocong Huang; Robert A Svoboda; Audrey J Lazenby; Jintana Saowapa; Nina Chaika; Ke Ding; Margaret J Wheelock; Keith R Johnson
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

7.  Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress.

Authors:  Hong Peng; Jiao Yang; Guangyi Li; Qing You; Wen Han; Tianrang Li; Daming Gao; Xiaoduo Xie; Byung-Hoon Lee; Juan Du; Jian Hou; Tao Zhang; Hai Rao; Ying Huang; Qinrun Li; Rong Zeng; Lijian Hui; Hongyan Wang; Qin Xia; Xuemin Zhang; Yongning He; Masaaki Komatsu; Ivan Dikic; Daniel Finley; Ronggui Hu
Journal:  Cell Res       Date:  2017-03-21       Impact factor: 25.617

8.  Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.

Authors:  Kshama Gupta; Jeremy C Jones; Virginea De Araujo Farias; Yuri Mackeyev; Pankaj K Singh; Alfredo Quiñones-Hinojosa; Sunil Krishnan
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

Review 9.  Discoidin domain receptor functions in physiological and pathological conditions.

Authors:  Birgit Leitinger
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.